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Abstract
Background—To define and evaluate coronary contrast opacification gradients using
prospectively ECG-gated single heart beat 320-detector row coronary angiography (CTA).
Methods and Results—Thirty-six patients with normal coronary arteries determined by 320 ×
0.5 mm detector row coronary CTA were retrospectively evaluated with customized image post-
processing software to measure Hounsfield Units (HU) at 1 mm intervals orthogonal to the artery
center line. Linear regression determined correlation between mean HU and distance from the
coronary ostium (regression slope defined as the distance gradient Gd), lumen cross-sectional area
(Ga), and lumen short axis diameter (Gs). For each gradient, differences between the three
coronary arteries were analyzed with ANOVA. Linear regression determined correlations between
measured gradients, heart rate, body-mass index (BMI), and cardiac phase. To determine
feasibility in lesions, all three gradients were evaluated in 22 consecutive patients with left anterior
descending artery lesions greater than or equal to 50% stenosis. For all 3 coronary arteries in all
patients, the gradients Ga and Gs were significantly different from zero (p<0.0001), highly linear
(Pearson r values 0.77-0.84), and had no significant difference between the LAD, LCx, and RCA
(p>0.503). The distance gradient Gd demonstrated nonlinearities in a small number of vessels and
was significantly smaller in the RCA when compared to the left coronary system (p<0.001).
Gradient variations between cardiac phases, heart rates, BMI, and readers were low. Gradients in
patients with lesions were significantly different (p<0.021) than in patients considered normal by
CTA.
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Conclusions—Measurement of contrast opacification gradients from temporally uniform
coronary CTA demonstrates feasibility and reproducibility in patients with normal coronary
arteries. For all patients the gradients defined with respect to the coronary lumen cross-sectional
area and short axis diameters are highly linear, not significantly influenced by the coronary artery
(LAD vs LCx vs RCA), and have only small variation with respect to patient parameters.
Preliminary evaluation of gradients across coronary artery lesions is promising but requires
additional study.
Keywords
computed tomography; coronary vessels; imaging
Introduction
The number and width of CT detector rows determine the craniocaudal coverage per gantry
rotation. Coronary CT angiography (CTA) with 64 detector rows, each 0.5 mm wide,
simultaneously records 32 mm (64 × 0.5 mm) of image data per gantry rotation. Thus,
multiple gantry rotations are combined for image interpretation; each rotation contributes a
cardiac subvolume. Spatial misalignment between subvolumes is termed stair-step or slab
artifact. Temporal misalignment between subvolumes for coronary contrast opacification
refers to differences in attenuation induced by time differences between acquisitions of the
superior versus inferior subvolumes.
Wide area detector CT provides up to 160 mm (320 × 0.5 mm detector rows) craniocaudal
coverage, eliminating spatial and temporal misalignment in coronary CTA. Whole volume
acquisition enables quantification of the spatial variation in Hounsfield Units (HU) over the
entire coronary at a single point in time. We define the term “coronary contrast opacification
gradient” to describe these changes. If these parameters could be rapidly and reproducibly
computed, they would have the potential to extend the role of cardiac CT beyond coronary
artery morphology alone. One advantage could be realized in patients with diffuse coronary
artery disease (CAD) where the lumen area is diffusely smaller than normal 1,2 and thus
there is no normal reference segment for quantitative measures. Moreover, lesions with less
than 50% narrowing in these patients are considered a substrate for plaque rupture and acute
coronary syndrome. 3-5
An initial experiment of normal coronary arteries imaged by CT in a single R-R measured
the difference of the mean HU between the ostium and the point where the normal vessel
tapered to 2.5 mm diameter. This work showed a small but consistent decrease in contrast
opacification from the proximal to distal coronary artery. 6
This project extends the quantitative assessment of normal coronary contrast attenuation by
sampling coronary HU every 1 mm along the artery. This high rate of sampling enables
evaluation of opacification gradients as opposed to difference measurements. Although
coronary segmentation is available for several post-processing software packages,
customized software is required to extract the mean HU orthogonal to the center line at 1
mm intervals. Using a customized software package developed for coronary contrast
opacification gradients, the primary purpose of this study was to demonstrate that three
opacification gradients can be noninvasively measured using single heart beat 320-detector
row CT in patients with normal arteries. The first gradient, the “distance gradient” (denoted
Gd), is defined as the change in HU per cm of coronary artery. The second and third
gradients are defined as the change in HU with respect to the coronary artery lumen area
(Ga) and short axis diameter (Gs) orthogonal to the center line, respectively. The second
purpose of this study was to evaluate the properties of the three gradients, including
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goodness-of-fit of the respective linear model, potential differences between the three main
coronary arteries, and the influence of patient heart rate and body mass index.
Materials and Methods
Patients
The institutional human research committee approved this retrospective study and waived
the need for written informed consent. All patients had clinical indications for coronary
CTA. We retrospectively evaluated 36 consecutive single R-R 320 × 0.5 mm detector
configuration (Toshiba AquilionOne Dynamic Volume CT, Tochigi-ken, Japan)
prospectively ECG-gated coronary CTA patients with normal coronary arteries (Table 1).
The diagnosis of normal coronary arteries was obtained from the CT imaging reports at our
institution. The phase window included 25% (60-85%) of the R-R interval; this protocol has
an estimated radiation dose of 5-6 mSv, depending on body habitus. Two patients were used
to study cardiac phase variation. One was in the 36 patient cohort described above. The
second was an additional patient with no CT evidence of CAD but who underwent
retrospective ECG gating without tube current modulation. Twenty-five consecutive patients
with ≥50% stenosis in the LAD were used to test feasibility of computing gradients from
prospectively ECG gated single R-R coronary CTA (Table 1). Three of these patients were
excluded because of errors in coronary segmentation; two from dense calcification and one
from a coronary stent. Of the remaining 22 patients included in the study, all 7 who
underwent conventional coronary angiography had confirmation of the LAD disease.
Three-hundred twenty detector-row CT images were acquired with 350 millisecond gantry
rotation time and 120 kV tube voltage. Among the total 58 patients, 43 were acquired at 400
mA (standard); 15 patients were imaged at 580 mA because of a large body habitus. All
patients received 80 ml iopamidol 370 mg I/ml (Isovue-370, Bracco Diagnostics, Princeton,
NJ) and 40 ml saline, both at 6 ml/sec, injected with a dual injector (EZEM Empower CTA
DUAL Injector, EZEM Inc, Lake Success, NY). Bolus tracking in the descending aorta was
performed using a 200 HU threshold.
The target heart rate for beta-blockade (intravenous metoprolol, 5 mg increments to a
maximum of 20 mg) was 65 beats per minute. There were no patients with contraindication
to beta-blockade, and there were no observed or reported side effects from the beta blockers.
All 58 patients received 0.4 mg sublingual nitroglycerine before imaging.
Coronary Vessel Segmentation
For each patient, at least one phase was identified to have excellent image quality for the left
anterior descending (LAD), left circumflex (LCx), and right coronary artery (RCA).
DICOM images from this phase were reformatted with a customized plugin for OsiriX 3.0.2
based on a 3D “virtual contrast injection” method. 7 The following data was obtained from
the region of interest (ROI) defined as the entire segmented lumen at every millimeter
orthogonal to the coronary center line beginning at the ostium and ending where each vessel
had adequate segmentation, typically when the diameter tapered to roughly 1.5 mm: the
mean and maximum attenuation (in HU), the cross-sectional area (in millimeters squared),
and the shortest diameter of the cross-section or the “short axis” (in millimeters). For each
vessel, a cardiovascular imager with 6 years of experience manually determined the distal
point and corrected the lumen ROIs generated by the vessel segmentation software when
required, for example at branch points.
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Definition of Coronary Opacification Gradients
The three opacification gradients were computed using linear regression from the segmented
data. The distance gradient, denoted Gd, has units of HU per centimeter of coronary artery
and is defined as the slope of the regression model, measured HU = location × Gd + c, where
the “location” is the distance distal to ostium in centimeters, and c is a constant determined
from the linear regression. Note that Gd is inherently less than zero since HU measurements
decrease distally in a normal coronary artery imaged with 320-detector row CT.6 The area
gradient, denoted Ga, has units of HU per millimeter squared and is defined as the measured
HU = area × Ga + c where “area” refers to the cross-sectional lumen area orthogonal to the
center line. The short axis diameter gradient, denoted Gs, has units of HU per millimeter and
is defined as measured HU = short axis diameter × Gs + c. As with the distance gradient, the
slopes and constants for the linear equations representing the cross-sectional area and short
axis diameter gradients were obtained using linear regression.
Coronary opacification gradients for normal patients were computed for both the mean and
maximum HU values from the vessel segmentation. Detailed analyses of contrast
opacification uses the mean HU over the entire lumen. The maximum HU gradients were
used for validation in normal vessels; for normal arteries the maximum HU gives an
assessment relatively independent of partial volume effects.
Statistical analyses—For regression models, the Pearson correlation coefficient (r) was
used to determine the strength of correlation, i.e., the goodness-of-fit. A magnitude of
r<0.25 indicates low correlation, 0.25< r< 0.5 moderate, 0.5< r<0.75 strong, and r>0.75
excellent. We considered p<0.05 (two-sided t-test) to define a regression coefficient (slope)
significantly different from zero.
1. General properties of gradients: The Pearson correlation coefficient and corresponding
p-value were used to determine if the gradient models defined were appropriate for each
normal coronary artery, i.e., if the correlation was at least moderate (r>0.25), and the
corresponding gradient (slope) was non-zero (p<0.05). Only gradients meeting these criteria
were further evaluated.
Gradients in patients with no CT evidence of CAD underwent one-way analysis of variances
(ANOVA) to test the hypothesis that there is no significant difference of the mean gradient
between the 3 major coronary arteries (LAD, LCx, and RCA).
Agreement between gradients determined from the mean versus maximum HU
measurements in normal vessels was assessed using the Pearson correlation coefficient (r).
2. Variability and reproducibility of measured gradients
Heart Rate and Body Mass Index: For the 36 normal patients, linear regression models
were used to determine if each of the three gradients was correlated to patient heart rate and
body-mass index for each vessel. The regression coefficients were used to estimate the
influence of heart rate variations between 55 and 65 beats per minute and patients with a
body mass index between 20 and 30 kilograms per meter squared.
Drift Over Cardiac Phases: Linear regression models were used to evaluate for drift (i.e., a
statistically significant trend) in gradient magnitude during the cardiac cycle for the LAD in
the one patient who underwent retrospective ECG gating (5-95%) plus one of the 36 normal
patients for whom segmentation was performed in all three arteries at all 1% intervals
between 60-85%.
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Inter-observer Agreement: In the patient for whom segmentation was performed at all 1%
intervals between 60-85%, a second cardiovascular imager independently segmented and
corrected all three arteries at 9 phases (3% intervals). Inter-observer agreement was assessed
using the Pearson correlation coefficient between gradient magnitudes resulting from the
individual segmentations.
3. Preliminary evaluation of gradients in patients with coronary artery disease: For the
CAD cohort, all 22 patients had ≥50% LAD stenosis as determined by CT. Gradients in the
LAD were computed using the same method as patients with normal coronary arteries. A
two-sided t-test was used to assess whether each of the three gradients was the same in
vessels without versus in vessels with lesions. In this case, p< 0.05 indicated that the mean
gradient was significantly different in between the two groups of patients.
4. Phantom experiment to determine potential HU changes over the coronary artery
field of view: To assess potential attenuation drift inherent to the CT scanner, HU
differences were evaluated via a Delrin cylinder phantom (TOS phantom, Toshiba Medical
Systems Corporation, Otawara, Japan), chosen because the properties (330 HU, density =
1.42 g/cm3) roughly match a normal contrast enhanced coronary lumen. The phantom was
scanned with one 0.5 second axial 320 × 0.5 mm detector row gantry rotation, 120 kV, 300
mA rotation, and 5mm reconstruction thickness. The Delrin CT number was measured via
placement of a 330 mm2 circular ROI every 5 mm over the central 13 cm of the gantry,
corresponding to the location of the coronary arteries from which the three gradients are
computed.
Results
1. General Properties of gradients
The cross-sectional area (Ga) and short axis diameter (Gs) opacification gradients (Figure 1)
are significantly different from zero (p=0.0001) in all three vessels for all 36 patients with
no CT evidence of CAD. Among these normal vessels, the distance gradient was not
significant in the RCA for two patients and in the LAD in one patient. These were the only 3
vessels, i.e., less than 1% among a total of 324 gradients measured in 108 vessels (36
patients multiplied by 3 vessels per patient, multiplied by 3 gradients per vessel), with a
Pearson r<0.25, indicating a non-linear association of HU and distance from the ostium.
Table 2 considers the linear model fits in the remaining 105 vessels for the distance gradient
and all 108 vessels for the other two models.
Regarding goodness-of-fit, the mean Pearson r values for Gs and Ga indicated excellent
correlation, ranging from 0.79 (RCA) to 0.84 (LAD) and 0.77 (RCA) to 0.82 (LAD),
respectively. The mean Pearson r values for Gd were slightly lower, ranging from 0.68 in the
RCA to 0.80 in the LAD. Differences in significance, p, and correlation, r, between Ga and
Gs were very small, likely reflecting the fact that cross-sectional area and short axis diameter
are strongly related in normal coronary arteries.
Comparing the gradient between the three coronary arteries in all 36 patients (Figure 2),
there was no significant difference for Ga (ANOVA p=0.503) and Gs (ANOVA p=0.625).
However, the magnitude of Gd for the RCA was significantly smaller than in the LAD and
LCx (ANOVA p<0.001).
Using the maximum HU contrast opacification gradients to evaluate the potential influence
of volume averaging, less than 5% of the 324 gradients had a Pearson r<0.25, as opposed to
<1% for the mean HU gradient definition, reflecting the fact that the maximum is not a
smooth statistic. The maximum HU gradient was highly correlated to the mean HU gradient
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across all patients and gradient models, indicating that volume averaging does not alter
patient-specific differences in the measured gradient magnitude (Table 3, r>0.9 for 5 of 9
gradient models).
2. Variability and reproducibility of measured gradients
Heart Rate and Body Mass Index—Gradients exhibited significant (p<0.05) low to
moderate (Pearson r<0.5) correlations with heart rate and body-mass index (Table 4). Over
the range of standard coronary CTA patients, namely those with HR between 55 and 65
beats per minute and body mass index between 20 and 30 kilograms per meter squared, the
correlated gradient change was less than one standard deviation of the corresponding
gradient observed over the 36 patient cohort with no CAD.
Drift Over Cardiac Phases—In the single patient with reconstructions at every 1%
intervals in diastole, all three gradients exhibited strong correlation with cardiac phase in the
RCA and LCx (Table 5). None of the three gradients was correlated to cardiac phase in the
LAD (Table 5). The LAD was further evaluated throughout the entire R-R interval for the
patient with retrospective ECG-gated acquisition. For these reconstructions spaced by 5% of
the R-R interval, none of the three gradients was correlated to cardiac phase in the LAD
(Table 5). Example correlations in the RCA and LAD for Ga are provided in Figure 3.
The variation of the gradient magnitude through the cardiac cycle was smaller than its
variation in the 36 patient cohort with no CAD (Figure 4). Gradients in the LCx
demonstrated the largest variation with respect to cardiac phase.
Inter-observer Agreement—Interobserver agreement was excellent for all gradients and
arteries (Table 6). In addition to high agreement, the variation in gradient magnitudes
observed between readers (Table 6) was significantly smaller than both the entire sample of
arteries as well as the observed cardiac phases in one patient (Figure 4).
3. Preliminary evaluation of gradients in patients with coronary artery disease
All three gradients in all 22 patients with the LAD lesions were significantly different from
zero (p=0.0001, Figure 1). Regarding goodness-of-fit, the mean Pearson r values for Gs and
Ga indicated strong correlation; for Gd there was excellent correlation (Table 2). The slight
lower Pearson r values for Gs and Gd likely reflect the more challenging segmentation and
subsequent imprecision in the short axis diameter and area measurements for vessels with
lesions.
All three gradients in patients with LAD stenosis ≥50% had mean values significantly
different (p<0.021) compared to the corresponding gradients in patients with no CT
evidence of CAD (Figure 1). The difference was most consistent for the short axis diameter
gradient (Figure 2b).
Phantom experiment to determine potential HU changes over the coronary artery field of
view
The mean (range) HU measurements in the Delrin cylinder were 329.6 HU (327.8 – 332.3
HU). The very small gradient over the 4.5 HU range had a slope of 0.0225 HU/cm with the
HU decreasing as measurements approached the tube anode as determined by the orientation
of the phantom within the scanner.
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Discussion
Wide area detector CT enables noninvasive quantitative assessment of coronary contrast
changes with temporal uniformity. The current data confirms that opacification gradients
exist in patients with normal coronary arteries. Customized image segmentation software is
required to quantify attenuation differences over short coronary distances.
Until recently, coronary CTA was performed with retrospective ECG gating so that cardiac
function could be estimated in conjunction with coronary artery disease. Because of the
lower radiation dose, prospective ECG gating is used with increasing frequency; 8 with this
acquisition protocol, data regarding cardiac function is not available. State-of-the-art multi-
detector CT technology is now moving closer to acquiring information regarding myocardial
perfusion. However, perfusion data requires specialized protocols, ideally performed at both
rest and stress. Unlike the assessment of wall motion or perfusion, coronary contrast
opacification gradients are simple parameters that only require post-processing tools.
We defined, computed, and analyzed three coronary contrast opacification gradients to
quantify mean HU changes in normal coronary arteries. The distance gradient Gd is the
linear fit that most resembles earlier work that quantifies the decrease in HU between two
points in a coronary artery.6 When compared to the cross-sectional area and short axis
diameter gradients, the distance gradients may be considered easier to interpret, but in a
small number of cases demonstrate nonlinearities that may limit potential clinical use. One
possible reason for the slightly lower goodness-of-fit for Gd compared to Gs and Ga is the
presence of branching vessels. Those linear fits inherently measure changes in HU with
respect to coronary lumen size and thus are expected to be less sensitive to highly variable
coronary branching patterns, a potential cause of nonlinearity in Gd. Considering only
significance and correlation, the short axis diameter gradient slightly outperformed the
cross-sectional area gradient. Neither of those gradients demonstrated a significant
difference between the three major coronary arteries. The distance gradient was however
significantly different in the RCA than in the left coronary system.
In vessels with no wall calcification, gradients computed using maximum HU values are
insensitive to partial volume averaging since the voxel with maximum HU for every cross-
section is expected to contain only contrast-enhanced blood. In the 108 normal vessels, the
maximum HU gradients had excellent correlation with the mean HU gradients. While small
wall calcium (below visual threshold for detection) could not be definitively excluded, the
excellent correlation for all vessels argues that partial volume effects and imperfect
segmentation do not skew gradient magnitude differences between patients.
The potential utility of gradients in coronary CTA will depend on the ease and
reproducibility of the measurements as well as separation between vessels with and without
CAD. Regarding gradient measurements, the required customized software can be used on
current DICOM coronary CTA data. Regarding reproducibility, for the patients with no
CAD, we observed limited impact of varying HR, BMI, cardiac phases, and different
cardiovascular readers in comparison to variations in the patient population. In fact, many
correlations such as those for HR and BMI were no more than moderate and may be
irrelevant in larger populations. Regardless, the ensemble of results well-characterizes the
distribution of all gradients in patients with no CAD, the primary purpose of the study.
Our understanding of gradients in diseased vessels is very sparse. However, the preliminary
evaluation in 22 patients with LAD disease suggests a consistent difference with normals.
Additional studies will be required to confirm the differences between patients with and
without CAD for different lesion types. Initial studies will focus on patients with both focal
lesions and diffuse CAD, as the latter group is expected to have differences over long
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segments of the coronary arteries and have a graded, continuous pressure decrease along the
length of the artery.9
Normal coronary arteries do not have a measurable drop in pressure along their course.
However, the reproducibility of the gradient data argues that differences in opacification are
linked to flow. Regarding coronary lesions, the most important factor to determine
resistance is the minimum cross-sectional area,10 incorporated into the definition of Ga.
If one or more gradients can be reliably measured across lesions or in patients with diffuse
CAD, and if those gradients differ from the normal coronary gradients established in this
work, these parameters could potentially be incorporated into the evaluation of CAD. It is
important to acknowledge that the confirmation of clinical utility will ultimately require
measures of clinical outcome from multiple centers, and thus the study of contrast
opacification gradients is only in its infancy. However, the low level of HU drift for the
scanner and the ease in computing the gradients makes it amenable for future work.
Limitations
All patients received sublingual nitroglycerine for coronary vasodilatation, increasing
coronary blood flow. It is not possible to determine the influence on the calculated gradients,
but the point could be relatively moot since essentially all coronary CTA is performed after
nitroglycerine administration. All patients had identical iodinated contrast injection and
bolus tracking protocols. However, the influence of contrast media volume, rate of injection,
and iodine concentration will also require further evaluation. All patients were evaluated on
a single CT platform that offers temporal uniformity; that is, data from the entire coronary
tree was acquired at a single phase of opacification. Future work will evaluate if and how the
gradients change when the image data is acquired on different CT platforms.
Another limitation is that there is no coronary catheterization confirmation that the patients
presumed to have no CAD are in fact normal. This evaluation was performed
retrospectively, and because of the high negative predictive value of CT, patients with a
normal study typically require no additional imaging. Future work using patients with and
without CAD will confirm the presence of opacification gradients in patients with no CAD
confirmed with coronary catheterization. Finally, refinements in the post-processing
software will advance our ability to rapidly determine the gradients with little user input.
The present software requires manual correction near branch vessels. The time for a
complex coronary system (all vessels) is 45 minutes (standard deviation 10 minutes).
Further refinements to the software are expected to reduce the time burden to levels
compatible with clinical workflow.
Conclusion
The mean HU changes along the course of a coronary artery are termed contrast
opacification gradients and can be reproducibly evaluated with a 320-detector row CT
acquisition. In normal coronary arteries, the gradients computed with respect to cross-
sectional lumen short axis diameter and area orthogonal to the coronary center line are
significant, linear, and not significantly influenced by the coronary artery (LAD vs LCx vs
RCA). The moderate influence from BMI, heart rate, and cardiac phase variations are
probably compatible with changes in motion artifact and signal to noise ratio currently
experienced in clinical coronary CTA. Studying changes between coronary arteries in the
same patient and changes within individual coronary arteries may provide insight with
respect to coronary physiology not previously accessible noninvasively. Early experience in
vessels with lesions demonstrates feasibility and further studies are warranted. The clinical
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utility of these measurements will rely on potential differences when these new parameters
are studied in patients with CAD.
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Figure 1.
Linear fit of the distance (a), short axis diameter (b), and cross-sectional area (c) gradients in
the left anterior descending (LAD) for a patient without and a patient with CT evidence of
CAD, with results of linear regression.
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Figure 2.
Mean and standard deviation of the distance (a), short axis diameter (b), and cross-sectional
area (c) gradients for the three major coronary arteries in 36 normal RCA, LAD, and LCx
arteries, as well as corresponding gradients in 20 patients with LAD disease. Only the
distance gradient has a significant difference between normal coronary arteries; the RCA is
significantly closer to zero than the LAD and LCx (ANOVA p < 0.001). Patients with LAD
stenosis have significantly different gradient magnitudes than normals (p < 0.011).
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Figure 3.
Variation of area gradient with respect to cardiac phase in diastole in one RCA (a) and
through the entire cardiac cycle in the LAD of a different patient (b). Linear regression
results are shown for the RCA, where the trend was significant (Table 5, p < 0.05).
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Figure 4.
Standard deviation of the magnitude for all three gradients for the 36 patients with no CT
evidence of CAD (blue bars), 60-85% cardiac phase in one patient (red bars), 5-95% cardiac
phase at 5% intervals in a single LAD in one patient (purple bars), and between
cardiovascular imagers performing the segmentation for 9 cardiac phases in one patient
(green bars).
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Table 1
Clinical indications, patient demographics, and cardiac risk factors for the 36 patients without CAD and 22
patients with CAD imaged with prospective single R-R 320-detector row CT acquisition.
Patients without CAD Patients with CAD Total
Number of patients 36 22 58
Indication
Chest pain 18 11 29
Pre-surgical evaluation 8 1 9
Other* 3 4 7
Asymptomatic 7 6 13
Demographics
Male 19 16 35
Mean age (range) 48.7 (30-66) 59.3 (35-78) 52.7 (30-78)
BMI kg/m2, (range) 27.8 (17.0-41.6) 27.5 (21.3-36.9) 27.7 (17.0-41.6)
Risk Factors
 Dyslipidemia 19 11 30
 Hypertension 13 18 31
 Obesity 10 3 13
 Diabetes 0 4 4
 Smoking 5 3 8
Beta-blockade
None 6 10 16
5 mg 12 6 18
7.5 – 10 mg 9 1 10
>10 mg 9 5 14
Heart Rate
mean bpm (range) 58.2 (45-75) 58.3 (48-70) 58.3 (45-75)
≤ 65 bpm 34 19 53
> 65 bpm 2 3 5
*
Other includes dyspnea and/or arm numbness/tingling
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Table 3
Correlations between mean and maximum HU contrast opacification gradients in 36 patients with no CT
evidence of CAD. The regression coefficient indicates the relationship between the magnitude of the contrast
opacification gradient obtained from maximum HU measurements to that obtained from mean HU
measurements.
Gradient Vessel Regression coefficient Pearson r
Distance (Gd, HU/cm)
RCA 2.09 0.95
LAD 2.11 0.92
LCx 2.35 0.79
Short Axis Diameter (Gs, HU/mm)
RCA 2.16 0.89
LAD 2.29 0.92
LCx 2.28 0.81
Area (Ga, HU/mm2)
RCA 2.22 0.92
LAD 2.25 0.94
LCx 2.85 0.89
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Table 5
Correlations of gradients with cardiac phase in all three vessels at 1% phase intervals between 60% and 85%
cardiac phase in one patient, and in the LAD at 5% intervals between 5% and 95% cardiac phase in another
patient. Significant trends (highlighted) are observed for all three gradients in the RCA and LCx but not the
LAD.
Gradient Phase Range p-value Correlation Coefficient (r)
RCA
Distance (Gd) 60% – 85% 0.004 -0.55
Short Axis Diameter (Gs) 60% – 85% 0.003 0.56
Area (Ga) 60% – 85% 0.001 0.66
LAD
Distance (Gd)
60% – 85% 0.51
5% – 95% 0.905
Short Axis Diameter (Gs)
60% – 85% 0.981
5% – 95% 0.137
Area (Ga)
60% – 85% 0.630
5% – 95% 0.063
LCx
Distance (Gd) 60% – 85% 0.001 0.78
Short Axis Diameter (Gs) 60% – 85% 0.001 0.67
Area (Ga) 60% – 85% 0.001 0.72
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Table 6
Difference in gradient analyzed by two independent cardiovascular imagers (R1 and R2) for 9 diastolic cardiac
phases equally spaced between 60% and 85% in one patient, and corresponding inter-observer agreement
(Pearson correlation r).
Gradient Vessel R1-R2 Difference (Mean ± SD) Pearson r
Distance (Gd, HU/cm)
RCA -0.75 ± 0.97 0.93
LAD -0.24 ± 0.19 0.99
LCx 0.26± 2.44 0.87
Short Axis Diameter (Gs, HU/mm)
RCA 1.72 ± 3.31 0.91
LAD 4.26 ± 3.00 0.95
LCx -0.22± 11.42 0.79
Area (Ga, HU/mm2)
RCA 0.74 ± 0.95 0.95
LAD 1.08 ± 0.73 0.95
LCx 0.58 ± 3.24 0.92
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